Esta buscando: 2,3,6-Trifluorobenzaldeh\\u00EDdo

Numero del catalogo: (BOSSBS-9500R-HRP)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promoción

Numero del catalogo: (EHERC17883600)

Proveedor: EHRENSTORFER

Descripción: 2,3,6-Trimetilfenol

UOM: 1 * 0,25 g

Promoción

Numero del catalogo: (390-0999)

Proveedor: VWR Collection

Descripción: Las incubadoras digitales VWR IL 10, IL 23 y IL 56 son una solución económica de ahorro de espacio para aplicaciones de hematología y microbiología. Ajuste de la temperatura en incrementos de 0,1 °C hasta un máximo de 70 °C. Los elementos calefactores están incorporados en la base de la carcasa y en las paredes para asegurar la uniformidad y estabilidad de la temperatura. La VWR IL 10 está disponible con ventanilla transparente de plexiglás (con una perfecta visibilidad) o con ventanilla pintada opaca de Plexiglás® para la protección de muestras fotosensibles. La carcasa y el marco de la puerta están fabricados totalmente de acero dulce con recubrimiento epoxi.

UOM: 1 * 1 UN

Certificados Promoción

Numero del catalogo: (BOSSBS-9500R-A680)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation. Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesised in the liver and circulates as an inactive precursor. Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds. Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease.

UOM: 1 * 100 µl

Promoción

Numero del catalogo: (LBCP3971830)

Proveedor: LABCONCO

Descripción: XPert™ balance enclosures provide user protection by keeping powders, particulates and fume contained during weighing procedures. They are well suited for pharmaceutical research and other laboratory applications involving weighing of toxic substances. These vented balance safety enclosures may be ducted to the outside or connected to the FilterMate Portable Exhauster to be exhausted back into the laboratory through HEPA filters, carbon filters, or a combination of both HEPA and carbon filters.

UOM: 1 * 1 UN

Promoción

Numero del catalogo: (EHERC17773600)

Proveedor: EHRENSTORFER

Descripción: 2,3,6-Triclorofenol

UOM: 1 * 0,1 g

Promoción

Numero del catalogo: (BOSSBS-9500R-CY7)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promoción

Numero del catalogo: (BOSSBS-9500R-A555)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promoción

Numero del catalogo: (BOSSBS-9500R-A350)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promoción

Proveedor: Apollo Scientific

Descripción: Vancomycin is a glycopeptide antibiotic. It exerts its action by inhibiting the formation of the peptidoglycan polymers of the bacterial cell wall. Often used incombination with cefotaxim or carbenicillin.

Numero del catalogo: (BOSSBS-9500R-A488)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promoción

Numero del catalogo: (BOSSBS-9500R-A750)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation. Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesised in the liver and circulates as an inactive precursor. Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds. Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease.

UOM: 1 * 100 µl

Promoción

Numero del catalogo: (BOSSBS-9500R-A647)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promoción

Numero del catalogo: (BOSSBS-9500R-CY5)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promoción

Numero del catalogo: (EHERC17713600)

Proveedor: EHRENSTORFER

Descripción: 2,3,6-Tricloroanísol

UOM: 1 * 0,1 g

Promoción

Numero del catalogo: (BOSSBS-9500R-CY3)

Proveedor: Bioss

Descripción: Hemostasis following tissue injury involves the deployment of essential plasma procoagulants (prothrombin, and factors X, IX, V, and VIII), which are involved in a blood coagulation cascade that leads to the formation of insoluble fibrin clots and the promotion of platelet aggregation (1-3). Coagulation factor IX (plasma thromboplastic component, F9, F.IX, HEMB) is a vitamin K-dependent, single chain serine protease that is synthesized in the liver and circulates as an inactive precursor (3,4). Factor XIa mediated proteolytic cleavage of factor IX generates factor IXa, an active serine protease composed of a 145 amino acid light chain and a 236 amino acid catalytic heavy chain, linked through disulfide bonds (5). Genetic alterations at the Factor IX locus such as point mutations, insertions and deletions, can lead to hemophilia B, also known as Christmas disease (6).

UOM: 1 * 100 µl

Promoción